The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage? - Concepedia

Concepedia

Publication | Open Access

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

DOI Full Paper Access

11

Citations

22

References

2011

Year

Frank Wiesmann, Jan Vachta, Robert Ehret, Hauke Walter, Rolf Kaiser, Martin Stürmer, A Tappe, Martin Däumer, Thomas Berg, Gudrun Naeth,

AIDS Research and Therapy

References

	Year	Citations

Page 1